6231238
Last Update Posted: 2025-11-24
Recruiting
All Genders accepted | 18 Years + |
196 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Balance Acceptance and Commitment Therapy for Long COVID
This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT).
The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.
This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT).
The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.
Eligibility
Relevant conditions:
Post-COVID-19 Syndrome
Long COVID
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Trudie Chalder, PhD
trudie.chalder@kcl.ac.uk
+44 (0)20 7848 0406
Caroline Jolley, PhD
caroline.jolley@kcl.ac.uk
Data sourced from ClinicalTrials.gov